Postpartum Hemorrhage Market Devices Size, Industry
Analysis Report, Regional Outlook from 2017 to 2024.:
Global Market Insights Inc.
Growing pregnancy complications such as multiple pregnancies, upturned uterus and
large size of the baby will drive the Postpartum Hemorrhage (PPH) Devices Market.
Improvement in health care for women during childbirth to prevent and treat PPH will
further rise the demand for the PPH products. It is the foremost cause of maternal
mortality in low-income nations and the key cause of approximately one quarter of all
maternal deceases globally.
Rising cases of PPH around the world, increasing healthcare investment taken up by
multiple governments, along with the gradually increasing education programs and
awareness towards the complications caused will boost the industry growth.
Technological developments such as competency of the devices to soothe the condition
of the patient until perpetual treatment is provided and innovative testing methods will
drive the business.
The obstetric-gynecologic specialized manual instrument regulation of FDA controls the
postpartum hemorrhage device market. The products are classified as Class II devices,
by the regulatory bodies. Regulations address the general controls counting necessities
for annual registration, listing of devices, decent manufacturing practice, labeling and
prohibitions against adulteration and misbranding. Medi?Cal FFS reimburses maternity
care including prenatal care, delivery, and instant postpartum care in U.S.
Based on product, the industry is categorized into Non-Pneumatic Anti-Shock Garment
(NASG), Uniject prefilled injection system, Uterine Balloon Tamponade (Condom
Catheters, Foley Catheter, BT-Cath balloon, Bakri balloon tamponade, Rusch balloon).
According to the WHO, obstetrics hemorrhage accounts for 127,000 deaths per annum
globally and is the foremost cause of maternal death. National statistics propose that
around 8% of these deaths are caused by PPH. Non-Pneumatic Anti-Shock Garment
leads the overall industry revenue by offering cost effectiveness, ease and lower
pressure to the body. Simplicity of the NASG adds to its utility for use in community
settings where health care providers have minimal training. Uterine Balloon
Tamponade market is likely to grow at a substantial rate over the forecast period owing
to effectiveness in management, simple arrangement and minimal adverse effect.
Browse key industry insights from the report “Postpartum Hemorrhage Market Devices
Size, Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Italy,
1 | Page